Last verified 2026-08-16

Prior authorization for sleep apnea treatment

Your clinician can diagnose sleep apnea, decide on treatment, and write the order. You may still be waiting days or weeks later because the insurer has not approved payment yet.

That is prior authorization: approval from the insurer before a treatment, drug, procedure, or piece of equipment is provided. The plan reviews your records against its coverage criteria before it agrees to pay.

One practical detail matters immediately. The insurer’s review clock does not start while the request is sitting in a clinic or equipment-supplier queue. Find out who is submitting it and when it was actually sent.

Which treatments commonly require it

PAP therapy often does not require prior authorization. Coverage is more commonly controlled by diagnostic requirements before treatment and an adherence rule after you receive the machine.

Oral appliances frequently do require prior authorization. Your file may need the sleep study, the treating practitioner’s order, and documentation that the proposed appliance is custom and adjustable.

Hypoglossal nerve stimulation almost always requires prior authorization and generally has the most detailed eligibility requirements among the major sleep apnea treatments.

Tirzepatide for OSA essentially always requires prior authorization. The request needs to identify obstructive sleep apnea as the reason for the prescription rather than submitting the drug as treatment for weight alone.

Published coverage policies do not always tell you whether prior authorization is required. In the payer policies we could read, only a minority explicitly answered that question. A plan can publish several pages of coverage criteria and still leave the pre-approval requirement off the same document.

→ What each payer publishes, by treatment

The 2026 federal changes

A federal rule that took effect on January 1, 2026 changed the prior-authorization process for several types of health plans.

For affected payers, an expedited request has to be decided within 72 hours and a standard request within 7 calendar days.

If the request is denied, the payer has to give a specific reason. That gives you and your clinician an actual objection to answer instead of only a generic denial code.

Affected payers also have to publish prior-authorization metrics every year, including approval rates, denial rates, approvals after appeal, and average decision time. Those reports let you see how often a payer denies requests and how long its decisions usually take.

The rule applies to Medicare Advantage plans, state Medicaid and CHIP fee-for-service programs, Medicaid and CHIP managed-care plans, and Qualified Health Plans on the federal exchange. Federal-exchange plans are covered by the rule overall but were excluded from the 72-hour and 7-day decision deadlines.

The rule does not apply to Original Medicare, Part D prescription drugs, employer self-funded plans, or plans sold on state-run exchanges. A large share of employer-sponsored coverage is self-funded, so do not assume the federal deadline applies to you just because your insurance comes through work.

What the request usually needs

For most sleep apnea treatments, the insurer starts with proof of the diagnosis. Your file commonly includes the sleep study, the breathing-event index reported on that study, and the event count. The test also has to be one the payer recognizes and has to meet the plan’s ordering requirements.

Your report may use an apnea-hypopnea index, or AHI, or a respiratory disturbance index, or RDI. Those are the abbreviations you will see again in coverage policies and denial letters, so keep a copy of the report rather than relying on a summary in your chart.

For an oral appliance, the file may also need an in-person evaluation by a physician or equivalent practitioner before the sleep test, an order written after the results were reviewed, and documentation that the proposed device is custom and titratable rather than prefabricated.

For hypoglossal nerve stimulation, payers usually add proof that PAP failed or could not be tolerated, along with criteria related to your anatomy and the severity of your apnea.

For medication, the request commonly includes the OSA diagnosis, documented severity, and a body mass index that meets the plan’s threshold. When the indication controls coverage, the prescription has to be submitted for sleep apnea rather than weight management.

Step therapy

Step therapy means the plan makes you try one treatment before it will pay for another. In sleep apnea, that first step is often PAP.

In the published policies we reviewed, the great majority of those covering hypoglossal nerve stimulation require documented PAP failure or intolerance before the implant can be approved.

If PAP is not working for you, tell the clinician managing it and have the reason documented. A chart note showing that you tried PAP and explaining why it failed or could not be tolerated can become part of the later authorization request. If you simply stop using the machine, there may be no record of the trial your next treatment requires.

Requesting an exception to a required first step

Plans have processes for requesting a step-therapy exception when the required first treatment is not appropriate. Examples include a contraindication, a documented reason the treatment will not work, or proof that you already tried it under another insurance plan.

Your prescriber makes the exception request and has to state the clinical reason. Preference alone does not establish a clinical exception.

If you already failed a required treatment while you had different insurance, get those records before the new request is submitted. New plans routinely restart step therapy from zero unless someone gives them the prior treatment history.

Find out who is submitting the request

The ordering practice or the equipment supplier usually submits the prior authorization, but responsibility differs across treatments and organizations. Do not assume the person who wrote the order is also the person sending the authorization.

When treatment is ordered, ask:

“Who is submitting the prior authorization, when will it be submitted, and how will I know the outcome?”

Once the office confirms submission, write down the date. If a federal or plan-specific deadline applies and passes without a decision, you have a concrete date to reference when you call.

If nobody can tell you when the request was submitted, the useful question is still whether the insurer has actually received it. A treatment order and a prior-authorization request are separate pieces of paperwork.

If the request is denied

You can appeal a prior-authorization denial. For plans covered by the 2026 rule, the requirement for a specific denial reason makes the appeal more targeted because the insurer has to identify what it says is missing or unmet.

Many prior-authorization denials are documentation problems. A missing sleep study, incomplete chart note, absent treatment history, or incorrect indication may be fixable without changing the treatment plan itself.

Read the stated reason before sending more records. If the denial says the plan never received documentation of PAP intolerance, sending another copy of the diagnosis alone will not answer it.

→ How to appeal a sleep apnea denial → Your payer’s published policies and appeal route

The requirements and timeframes described here are federal standards that apply to specific plan types as of the date shown. Your own plan controls your claim, and self-funded employer plans follow different rules. This is not legal or medical advice.